CD34 and acute lymphoblastic leukemia: A study by Schotteet al. comparing 397 miRNAs in 81 pediatric ALL cases against 17 normal CD34+ stem cell controls reported unique miRNA signatures for various ALL subtypes and found miR-143 and miR-140 to be 70- to 140-fold lower in B-cell ALL samples versus control67.